How FDA Trains Its Investigators and Inspectors to Review Sub-Systems for State of Compliance: What You Need to Do to Prepare for a Successful Inspection

Start Date : September 26, 2018
End Date : September 27, 2018
Time : 9:00 am to5:00 pm

Phone : (800) 447-9407
Email : globalcompliancepanel@gmail.com

Location :
Courtyard Arlington Crystal City/Reagan National Airport 2899 Jefferson Davis Highway Arlington, VA 22202 USA

Website

Description


Course “How FDA Trains Its Investigators and Inspectors to Review Sub-Systems for State of Compliance: What You Need to Do to Prepare for a Successful Inspection” has been pre-approved by RAPS as eligible for up to 12 credits towards a participant’s RAC recertification upon full completion.

Description:

Senior management takes responsibility for Quality and GXP compliance. It is not something delegated to the Quality unit or to the Regulatory Affairs group. Developing and implementing an effective Inspection readiness plan will help ensure better results, as well as a less stressful inspection. Planning strategically ahead will reduce document turn-around time, improve presentation skills from SMEs, and increase inspector confidence in the Quality System. Successfully completing an FDA inspection is critical to cGMP operations and commercial success. Implementing and maintaining robust quality systems is one element to accomplishing this goal. However, it is not the only element. Inspection preparation and management is another, equally important element to ensure a successful outcome. In fact, proper Inspection Management techniques can help mitigate the risk of receiving an observation for compliance gaps. Quality and GXP compliance are an opportunity, not an obligation, and are owned by everyone in the organization. For those interacting with FDA regarding submissions, as an example, every interaction with the FDA is a crucial moment for your development program, and meetings represent a culmination of compiled and scheduled work. Strategies, timelines, costs and complexity are all organized through this interaction – the stakes are high, and the outcomes are extremely important. It all comes down to strategic communication. Every facet of FDA meetings – from the information your company is providing, to scientific research and the tone and articulation of that information – must be conducted flawlessly. For example, for many medical device companies, a meeting with a US Food and Drug Administration (FDA) Advisory Committee is a high-profile, high-stress event. A successful meeting can assure regulators, patients and investors that a product is safe and effective, while an unsuccessful meeting can torpedo a product’s chances of a timely approval.


Why you should attend:

This seminar will offer learning on the following:


Who will benefit:

This seminar will provide an overview and in-depth snapshot of the entire process for preparing for and managing an FDA inspection and external regulatory inspections and for those companies which must establish proven and sustainable GXP compliance strategies and risk mitigation strategies when responding to a crisis. Employees who will benefit include all levels of management and departmental representatives from key functional areas and those who desire a better understanding or a “refresh” overview of the FDA inspection process from preparing for the inspections, during the inspections and post-inspection responsibilities and follow up activities with FDA, including:

Agenda:

Day 1 Schedule


Lecture 1: Introductions and Background


Lecture 2: FDA’s Inspectional Authority and History


Lecture 3: FDA Inspection Program Overview


Lecture 4: Key factors for a successful FDA inspection


Lecture 5: Quality System Readiness


Lecture 6: Organization Readiness


Lecture 7: Manage Inspection Outcomes


Lecture 8: Information and Documentation


Lecture 9: How should a firm prepare for an FDA inspection?


Lecture 10: Ways to train employees in view of the inspection


Lecture 11: How to ensure that required documentation is in place


Lecture 12: How to interact with the investigator-DO’s and DON’T’s


Lecture 13: What companies should do when the inspection ends


Lecture 14: How to reply to 483’s and Warning Letters


Lecture 15: Legal implications of non-compliance


Lecture 16: Why inspections are conducted and by what statutory authority


Lecture 17: The emphasis on systems-based inspections…and the IOM and other crucial FDA reference documents such as QSIT


Lecture 18: What is subject to FDA purview and what’s off-limits


Lecture 19: Understand and apply the do’s and don’ts and comprehend that preparation is the key to success


Lecture 20: What are the prohibited “Acts” and the enforcement categories that you need to deal with?


Lecture 21: What you need to know and do to prepare for, during and even after the inspection…and why your inspection response team is key


Lecture 22: The company’s Inspection Plan (SOP) can make or break the inspection depending on how to use it and training your personnel


Lecture 23: How to respond to findings and facilitating the documentation and remediation process…and reaching final closure


Lecture 24: Define clear responsibilities, roles and goals for personnel involved in FDA inspections and SOP development


Lecture 25: Exit Interview


Lecture 26: FDA interviewing employees and personnel


Lecture 27: Management Controls, Production and Process Controls, Design Controls, CAPA, and sub-systems

Day 2 Schedule


Lecture 1: Quality System, Facilities and Equipment System, Materials System, Production System, Laboratory Controls and Operations, Packaging and Labeling System


Lecture 2: Maintain, or return to, regulatory compliance and minimize downtime


Lecture 3: Establish a risk management plan in place to proactively manage compliance, including a crisis-management plan


Lecture 4: Set post-inspection deadlines and working closely with FDA’s regulatory partners


Lecture 5: Compliance remediation is the process of recognizing problems, creating a plan to correct and prevent them from occurring in the future, and executing to that plan to helps with your GxP Compliance Strategy.


Lecture 6: Guidance outlining clear recommendations for sponsors and for FDA staff and managers as well for Pre-Submission meetings as expected timeframes for scheduling meetings


Lecture 7: Mechanics of requesting any FDA meeting and what you need to know to be successful with communication style, approach and tactics


Lecture 8: Prioritize follow-up on warning letters and other enforcement actions


Lecture 9: Develop and implement a formal warning letter “close-out” process


Lecture 10: Untitled Letter and the Warning Letters


Lecture 11: Recent Trends and Enforcement Actions


Lecture 12: Mock Inspections and Mock Audits and why role playing is important


Recap of Day 1 and Day 2


Exercise on Day 2

 

Speaker:

David R. Dills

Global Regulatory Affairs & Compliance Consultant and President, NovaQual 

David R. Dills, Global Regulatory Affairs & Compliance Consultant, Interim President, currently provides global regulatory affairs, compliance and quality consultative services for early-stage and established Class I/II/III medical device, including combination products, In Vitro Diagnostics, nutraceuticals/supplements, cosmetics and biopharmaceutical manufacturers in multiple medical specialties and therapeutic areas on the global landscape, and has an accomplished record with more than 26 years of experience in the areas of Regulatory Affairs, Compliance and Quality Systems. He has been previously employed, with increasing responsibilities, by medical device manufacturers and consultancies, including a globally recognized CRO, and has worked directly with manufacturers engaged in compliance remediation activities and services involving consent decrees, CIA’s, warning letters,483 observations, and customer generated compliance events. He prepares for and conducts QS and regulatory audits He is currently acting and interim President at NovaQual LLC.

 

Location:  Washington, DC Date: September 26th & 27th, 2018 and Time: 9:00 AM to 5:00 PM

Venue:  Courtyard Arlington Crystal City/Reagan National Airport 2899 Jefferson Davis Hwy, Arlington, VA 22202, USA

Price:

Price: $1,495.00 (Seminar Fee for One Delegate)

Register for 5 attendees Price: $4,485.00 $7,475.00 You Save: $2,990.00 (40%)*

Register for 10 attendees Price: $8,222.00 $14,950.00 You Save: $6,728.00 (45%)*

Sponsorship Program benefits for seminar

For More Informationhttps://www.globalcompliancepanel.com/control/sponsorship

Contact us today!

NetZealous LLC DBA GlobalCompliancePanel

john.robinson@globalcompliancepanel.com

Toll free: +1-800-447-9407

Phone: +1-510-584-9661

 Website: http://www.globalcompliancepanel.com

 

Registration Link – https://www.globalcompliancepanel.com/control/globalseminars/~product_id=901747SEMINAR?seo

Follow us on LinkedIn: https://www.linkedin.com/company/globalcompliancepanel/

Like us our Facebook page: https://www.facebook.com/TrainingsAtGlobalCompliancePanel/

Follow us on Twitter: https://twitter.com/GCPanel

 

 

 

v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}

Normal
0

false
false
false

EN-US
X-NONE
X-NONE

/* Style Definitions */
table.MsoNormalTable
{mso-style-name:”Table Normal”;
mso-tstyle-rowband-size:0;
mso-tstyle-colband-size:0;
mso-style-noshow:yes;
mso-style-priority:99;
mso-style-parent:””;
mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
mso-para-margin-top:0cm;
mso-para-margin-right:0cm;
mso-para-margin-bottom:8.0pt;
mso-para-margin-left:0cm;
line-height:107%;
mso-pagination:widow-orphan;
font-size:11.0pt;
font-family:”Calibri”,sans-serif;
mso-ascii-font-family:Calibri;
mso-ascii-theme-font:minor-latin;
mso-hansi-font-family:Calibri;
mso-hansi-theme-font:minor-latin;
mso-ansi-language:EN-US;
mso-fareast-language:EN-US;}

Registration Info

 
Cost :     $1,495.00

Event link :    https://www.globalcompliancepanel.com/control/globalseminars/~product_id=901747SEMINAR?meetings4docs-sep-seo

Contact the Organizer

Organized by

Organized by globalcompliancepanel

NetZealous LLC DBA GlobalCompliancePanel ,
161 Mission Falls Lane, Suite 216, Fremont, CA 94539, USA.

GlobalCompliancePanel is a training source that delivers diverse, high quality regulatory & compliance trainings. These trainings are simple while being relevant and cost-effective while being convenient.

Tel: 800-447-9407
Email: globalcompliancepanel@gmail.com
Website: https://www.globalcompliancepanel.com/


Event Categories: Health & Nutrition.

Your Review

You must be logged in to post a comment.